BHL launches Posaconazole API for treating Mucormycosis (Black fungus) infections in Covid-19 patients equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
URL copied Image Source : PTI
Bajaj Healthcare on Friday launched Posaconazole API, used in treating Mucormycosis (black fungus) infection in COVID-19 patients.
Bajaj Healthcare on Friday launched Posaconazole API, used in treating Mucormycosis (black fungus) infection in COVID-19 patients. The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing.
Bajaj Healthcare said it will commence its commercial production from the first week of June 2021. Posaconazole is a triazole antifungal agent indicated for treating Mucormycosis patients. More than 11,000 cases of black fungal infection have been reported from different parts, forcing state governments to declare it an epidemic.
Faridabad (Haryana) [India], May 26 (ANI/PRNewswire): On 11-05-2021, Elofic celebrated 70th Anniversary of its founding and its triumphant growth over the years. Evolving from a cottage industry level to a globally renowned player, Elofic looks back and credits hard work, perseverance, business ethics and innovative thinking of its workforce for all the glories.
Visaka Industries Limited enters into multiple new business segments equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.